ELRIG reveals keynote speakers for Drug Discovery 2025
13 May 2025

Not-for-profit organisation for the global drug discovery community ELRIG has revealed the keynote speakers for its flagship event, Drug Discovery 2025.
Professor Heather Pinkett of the US Northwestern University and Pfizer's Dr Dafydd Owen will headline the event staged at the ACC in Liverpool from 21–22 October.
Pinkett, associate professor at Northwestern's department of molecular biosciences and director of its NIH molecular biophysics training programme, will present on day one.
Owen, senior scientific director at Pfizer brings 25 years’ experience in medicinal chemistry who has authored more than 80 research papers and patents, will present his keynote on the second day.
Dr Del Trezise, chair of ELRIG, and strategy development, laboratory products and services at Sartorius, said: “We’re thrilled to welcome Prof Pinkett and Dr Owen to Drug Discovery 2025. With over 3,000 delegates expected, this promises to be Europe’s leading event for the drug discovery community.”
The event offers free access to over 150 talks across 14 scientific tracks, covering topics robotics and automation, advanced models for drug discovery, approaches in neurodegenerative disease therapeutics, and sustainable drug development.
Collaborating organisations include SLAS, the British Pharmacological Society, the Royal Society of Chemistry, Cancer Research Horizons, The Protein Society, SiLA and Alzheimer’s Research UK.
To further its international offer, ELRIG has partnered with VisitBritain to provide the opportunity for global drug discovery researchers to experience the UK life science sector first-hand and contribute their perspectives to the conversation.
The conference will feature more than 20 exhibitors, a Breakthrough Zone for startups, a Tech Theatre, and dedicated events for early-career professionals. Awards will also recognise innovation, rising stars and individuals who have made outstanding contributions in the drug discovery field.